Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Non Operating Investment Income (2016 - 2025)

Updated

Gyre Therapeutics' Non Operating Investment Income was -$2,000 in Q4 2025, compared with $2,000 a year earlier.

Analysis

Gyre Therapeutics (GYRE) Non Operating Investment Income (2016 - 2025) Analysis & Trends

For FY2025, Non Operating Investment Income at Gyre Therapeutics came in at -$4,000.

  • In earlier years, Non Operating Investment Income was -$66,000 in FY2024, -$2.71 million in FY2023 and -$4,000 in FY2022.
  • The Q4 2025 figure marks the lowest quarterly Non Operating Investment Income since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Gyre Therapeutics 753.90 Mn 556.61 Mn 26.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,000.00
Sep 30, 2025 -1,000.00
Jun 30, 2025 -1,000.00
Dec 31, 2024 2,000.00
Jun 30, 2024 -68,000.00
Dec 31, 2023 -2.19 Mn
Sep 30, 2023 -526,000.00
Mar 31, 2023 4.74 Mn
Dec 31, 2022 -57.25 Mn
Jun 30, 2022 57.25 Mn
Mar 31, 2018 -116,000.00
Dec 31, 2016 1.43 Mn
Sep 30, 2016 804,000.00
API Access

Gyre Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GYRE&period=max&api_key=YOUR_API_KEY